
Publications and References
Critical role of caveolin-1 in ocular neovascularization and multitargeted antiangiogenic effects of cavtratin via JNK
Yida Jianga, Xianchai Lina, Zhongshu Tanga, Chunsik Leea, Geng Tianb, Yuxiang Dua, Xiangke Yina, Xiangrong Rena, Lijuan Huanga, Zhimin Yea, Wei Chena, Fan Zhangc, Jia Mib, Zhiqin Gaod, Shasha Wanga, Qishan Chena, Liying Xinga, Bin Wange, Yihai Caof, William C. Sessa, Rong Jua, Yizhi Liua and Xuri Lia, PNAS Early Edition, PNAS.1706394114
Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice
Jean-Philippe Gratton,1,2,5,6 Michelle I. Lin,1,2,5 Jun Yu,1,2 Erik D. Weiss,1,2 Zao Li Jiang,1 Todd A. Fairchild,1,2 Yasuko Iwakiri,4 Roberto Groszmann,4 Kevin P. Claffey,3 Yung-Chi Cheng,1 and William C. Sessa1,2,*
CANCER CELL, July 2003, Vol. 4, 31-39
Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell-permeable peptides
Pascal N. Bernatchez, Philip M. Bauer, Jun Yu, Jay S. Prendergast, Pingnian He, and William C. Sessa
PNAS, Vol. 102, No. 3, 761–766, January 18, 2005
In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation
Mariarosaria Bucci, Jean-Philippe Gratton, Radu Daniel Rudic, Lisette Acevedo, Fiorentina Roviezzo, Giuseppe Cirino & William C. Sessa
Nature Medicine, Volume 6, Number 12, 1362-1367, December 2000